Figure 1. Overall survival of patients according to their baseline lymphocyte counts (< 1 Giga/L or ≥ 1Giga/L) for patients enrolled in cohort A (A) and cohort B (B). Comparison of TCR diversity in healthy subjects and patients from cohorts A and B (C). Overall survival according to their baseline TCR diversity (≤ 33% or > 33%) for patients enrolled in cohort A (D) and cohort B (E).